Skip to content
Endologix is now Rhevera Medical. Learn more about our evolution.
Peripheral
Pounce System
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
Aortic
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFUs
About Us
About Rhevera
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator-Initiated Research
Contact Us
Peripheral
Pounce System
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
Aortic
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFUs
About Us
About Rhevera
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator-Initiated Research
Contact Us
Search
Back to News
February 6, 2017
Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board John McDermott to Continue as Chief Executive Officer
Prev
Previous
Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium
Next
Endologix Completes Patient Enrollment in the Ovation(R) LUCY Study First Prospective Study Evaluating EVAR in a Female Population
Next
